XOMA Royalty Corp. (XOMA)
32.14
+1.65
(+5.41%)
USD |
NASDAQ |
Dec 09, 13:21
XOMA Royalty EPS Diluted (Quarterly): 0.6991 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vistagen Therapeutics, Inc. | -0.5432 |
| Zevra Therapeutics, Inc. | -0.0097 |
| Tango Therapeutics, Inc. | 0.1431 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 10.35M |
| Revenue (Quarterly) | 9.351M |
| Total Expenses (Quarterly) | -0.998M |
| Enterprise Value | 437.54M |
| Gross Profit Margin (Quarterly) | 90.59% |
| Earnings Yield | 2.32% |
| Normalized Earnings Yield | -1.978 |